In the News
GNS Healthcare Featured in Harvard Business Review Article on AI in the Workplace
GNS Healthcare is featured in the July/August issue of the Harvard Business Review as part of the article “Collaborative Intelligence: Humans and AI are Joining Forces”, a discussion of new digital tools and how AI can complement and augment human capabilities rather...
read more
WBUR Covers Convergence of AI and Precision Medicine
June 8, 2018 – WBUR, the largest of the three Boston NPR-affiliates, produced a series on the biotech boom in Boston this week, coinciding with the 2018 BIO conference that took place at the Boston Convention Center from June 4-7. Today, reporter Karen Weintraub dove...
read moreColin Hill joins Bloomberg Baystate Business Radio Hour
Colin Hill, Chairman, CEO and Co-founder of GNS Healthcare, joined Bloomberg Boston Bureau Chief Tom Moroney and Radio News Anchors Peter Barnes and Pat Carroll on May 9 for their weekly C-Suite segment. Colin talks about the GNS Healthcare's approach to precision...
read moreEvents
Rock Health Enterprise Insights panel on AI in Pharma features Iya Khalil
Everyone is talking about AI and machine learning's potential for drug discovery, clinical trial management, and precision medicine. What’s less clear is how—and to what degree—these advancements will have ripple effects across the industry and for patients. Will...
read more
Iya Khalil presents at TEDx Waltham
On Thursday, June 14th GNS Co-Founder and Chief Commercial Officer Iya Khalil will give a talk entitled "Why I believe Math Will Save My Life The Second Time Around". The talk will explore the idea of using mathematics, AI, and machine learning to understand the...
read more
GNS Co-Founders Colin Hill and Iya Khalil Take Center Stage at BIO 2018
GNS Co-founders Colin Hill and Iya Khalil will address the convergence of AI and precision medicine in a pair of panel discussions at BIO 2018. Colin will be participating in a panel titled “Cutting Waste in the Link Between Big Pharma and Payers with Precision...
read morePress Releases
GNS Healthcare Presents Results of Metastatic Colorectal Cancer Collaboration with the Alliance for Clinical Trials in Oncology at ESMO 2018
Study identifies clinical and molecular drivers of survival at baseline to allow better risk stratification at initiation of treatment CAMBRIDGE, Mass.– [October 22, 2018] – GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic...
read moreGNS Healthcare Co-Founder and Chief Commercial Officer Iya Khalil Named to INC Magazine’s List of Top Female Founders for 2018
CAMBRIDGE, Mass.– October 5, 2018 – Each October, INC Magazine chooses leading women pioneers, entrepreneurs and innovators to profile in its annual Women Entrepreneurs issue. In their 2018 issue, GNS Co-Founder and Chief Commercial Officer Iya Khalil, PhD was...
read moreGNS Healthcare Names Healthcare Analytics Executive David Gascoigne as Chief Operating Officer
CAMBRIDGE, Mass.– October 3, 2018 – GNS Healthcare (GNS), a leading precision medicine company, has tapped data analytics veteran David Gascoigne as its Chief Operating Officer. Gascoigne has two decades of experience scaling and leading data analytics businesses in...
read more